Sanofi
French pharmaceutical company
SAN Euronext Paris · home listing
SNY NYSE
ISIN FR0000120578 SEC CIK 1121404 LEI 549300E9PC51EN656011
Follow Sanofi
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | €43.6B | €7.8B |
| FY24 | €41.1B | €5.6B |
| FY23 | €43.1B | €5.4B |
| FY22 | €43B | €8.4B |
| FY21 | €37.8B | €6.2B |
| FY20 | €36B | €12.3B |
| FY19 | €36.1B | €2.8B |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 77.2% | 14.5% | 17.9% |
| FY24 | 75.7% | 17.7% | 13.5% |
| FY23 | 74.8% | 18.3% | 12.5% |
| FY22 | 73.7% | 24.8% | 19.5% |
| FY21 | 71.3% | 21.5% | 16.5% |
| FY20 | 70% | 39.2% | 34.2% |
| FY19 | 71% | 8.7% | 7.8% |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | €4.8B | €5B |
| FY24 | €4.7B | €302M |
| FY23 | €4.5B | €593M |
| FY22 | €4.2B | €497M |
| FY21 | €4B | €382M |
| FY20 | €3.9B | €822M |
| FY19 | €3.8B | €9M |
- Sanofi
- Healthcare median
Show the numbers
| Year | Sanofi | Healthcare median |
|---|---|---|
| FY25 | 17.9% | −30.6% |
| FY24 | 13.5% | −47% |
| FY23 | 12.5% | −58% |
| FY22 | 19.5% | −80.4% |
| FY21 | 16.5% | −71.9% |
| FY20 | 34.2% | −62.2% |
| FY19 | 7.8% | −46.3% |